Polycyclic peptide antibiotic gallidermin
US5231013A · kind A · utility
7Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | May 18, 1989 |
| Grant date | Jul 27, 1993 |
| Priority date | — |
| Expiry date | May 18, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/882
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new polycyclic peptide antibiotic termed gallidermin is disclosed and described, together with a process for producing such antibiotic by fermination of a new microorganism, Staphylococcus gallinarum (DSM 4616).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.